Results 151 to 160 of about 319,385 (305)
Factors associated with non-optimal antiretroviral adherence among MSM and women living with HIV in South India: an exploratory analysis. [PDF]
Luc CM +5 more
europepmc +1 more source
Stillbirth in pregnancies with flat OGTT: Placental clues to occult maternal dysmetabolism
International Journal of Gynecology &Obstetrics, EarlyView.
Emma Bertucci +10 more
wiley +1 more source
Abstract Background The aim of this study is to determine whether the timing of metronidazole (MTZ) and amoxicillin (AMX) administration, relative to scaling and root planing (SRP), influences the clinical and microbiological outcomes of periodontal treatment.
Daiane Fermiano +10 more
wiley +1 more source
Adherence to perindopril/amlodipine/atorvastatin combination according to the administration strategy. [PDF]
Morabito G, Rea F, Corrao G, Mancia G.
europepmc +1 more source
Abstract Posttraumatic stress disorder (PTSD) symptoms and alcohol use frequently co‐occur and are mutually reinforcing. Few studies have examined how changes in PTSD severity influence subsequent changes in alcohol use, particularly in the context of comorbidity treatments. This secondary analysis utilized data from a clinical trial comparing 12 weeks
Lesia M. Ruglass +11 more
wiley +1 more source
Effectiveness of using manual pill organisers and pill reminder apps in improving medication adherence and health outcomes in the Indian elderly population receiving multiple medications (PORA-MEDAdhere): protocol for a 2×2 factorial randomised controlled trial. [PDF]
Apte A +11 more
europepmc +1 more source
Misinformation and women's health: Rebuilding trust in evidence‐based care
International Journal of Gynecology &Obstetrics, EarlyView.
Zainab Al‐Jawahiri
wiley +1 more source
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin +4 more
wiley +1 more source

